Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$170.77 - $211.65 $565,077 - $700,349
-3,309 Reduced 32.67%
6,819 $1.21 Million
Q2 2023

Jul 26, 2023

SELL
$185.01 - $212.05 $1.87 Million - $2.14 Million
-10,100 Reduced 49.93%
10,128 $1.92 Million
Q1 2023

May 04, 2023

BUY
$182.66 - $235.53 $37,993 - $48,990
208 Added 1.04%
20,228 $4.05 Million
Q4 2022

Jan 26, 2023

BUY
$185.53 - $241.31 $3.71 Million - $4.83 Million
20,020 New
20,020 $0
Q4 2020

Feb 09, 2021

SELL
$122.97 - $147.0 $1.91 Million - $2.28 Million
-15,500 Closed
0 $0
Q3 2020

Nov 03, 2020

SELL
$121.19 - $165.49 $96,952 - $132,392
-800 Reduced 4.91%
15,500 $2.26 Million
Q2 2020

Jul 21, 2020

SELL
$104.21 - $156.44 $917,048 - $1.38 Million
-8,800 Reduced 35.06%
16,300 $2.41 Million
Q1 2020

Apr 20, 2020

BUY
$93.12 - $133.99 $2.34 Million - $3.36 Million
25,100 New
25,100 $2.73 Million
Q2 2018

Aug 13, 2018

SELL
$88.31 - $107.8 $1.59 Million - $1.94 Million
-18,002 Closed
0 $0
Q1 2018

Apr 12, 2018

BUY
$115.92 - $148.54 $9,157 - $11,734
79 Added 0.44%
18,002 $2.14 Million
Q4 2017

Jan 11, 2018

BUY
$114.49 - $139.98 $2.05 Million - $2.51 Million
17,923
17,923 $0

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.